A new inter partes review, IPR2027-00029, has been filed at the Patent Trial and Appeal Board on October 30, 2026, in a proceeding titled Shining 3D Tech Co., Ltd. At this early stage, the docket signals the opening of a potentially important dispute for companies operating in the 3D scanning, additive manufacturing, and digital modeling space.

Based on the currently available docket information, the proceeding centers on a challenge to a patent associated with or asserted against Shining 3D Tech Co., Ltd. As with any newly filed IPR, the key questions for practitioners will be: which claims are targeted, what prior art has been raised, and whether the petition frames a broader strategy tied to district court litigation, ITC proceedings, or licensing negotiations.

The PTAB docket entry identifies the case and filing date, but practitioners should expect the most significant details to emerge through the petition and subsequent papers.

A new inter partes review proceeding at the Patent Trial and Appeal Board, IPR2027-00003, was filed on October 2, 2026, naming Shenzhen Lanhe Technologies Co., Ltd in the case caption. Although the currently available docket entry provides only limited public-facing detail, the filing itself is worth watching for patent litigators, portfolio managers, and in-house IP counsel tracking PTAB activity involving overseas technology companies and potentially high-volume enforcement targets.

At this stage, the caption indicates that the challenged patent is associated with Shenzhen Lanhe Technologies Co., Ltd., but practitioners should note that additional filings will be needed to confirm the specific patent number, the identity of the petitioner, and the complete set of asserted grounds.

Luxottica of America Inc. has filed a new inter partes review, IPR2026-00512, at the Patent Trial and Appeal Board on September 29, 2026. At this early stage, the filing itself is the key development: it signals that Luxottica is turning to the PTAB to challenge the validity of an asserted patent rather than limiting the fight to district court litigation or licensing negotiations.

Based on the docket caption, Luxottica of America Inc. is the petitioner.

Salesforce, Inc. has launched a new inter partes review at the Patent Trial and Appeal Board, filing IPR2026-00477 on September 24, 2026. Although the public docket caption identifies the petitioner as Salesforce, the filing is notable for what it may reveal about the company’s broader patent defense strategy and the kinds of prior-art arguments now being tested at the PTAB.

At this stage, the basic procedural posture is clear: Salesforce is asking the Board to review the validity of an issued U.S. patent through the IPR process, which allows petitioners to challenge patent claims on anticipation and obviousness grounds based on patents and printed publications.

Netskope, Inc. has filed a new inter partes review petition at the Patent Trial and Appeal Board, opening PTAB docket IPR2026-00474 on September 15, 2026. For patent litigators and in-house IP teams, this is the kind of proceeding worth monitoring early: even at the filing stage, an IPR can signal a broader enforcement dispute, a defensive campaign against a competitor’s portfolio, or a strategic effort to reshape parallel district court litigation.

At this stage, the publicly available docket information identifies Netskope, Inc. as the petitioner, but the full petition and accompanying papers will be critical to pin down the complete picture — including the specific patent being challenged, the patent owner, and the precise prior-art grounds asserted.

Amazon.com Services LLC has filed a new inter partes review petition at the Patent Trial and Appeal Board, opening IPR2026-00471 on September 11, 2026.

Amazon.com Services LLC has filed a new inter partes review petition at the Patent Trial and Appeal Board, opening IPR2026-00471 on September 11, 2026. At this early stage, the PTAB docket indicates that Amazon is the petitioner, but practitioners will want to monitor the record closely for the identity of the patent owner, the specific patent number being challenged, and the prior-art combinations asserted in the petition as those details become available on the docket.

An IPR filing alone can be strategically significant.

Zoom Communications, Inc. has launched a new inter partes review at the Patent Trial and Appeal Board, filing IPR2026-00470 on September 2, 2026. The proceeding adds another potentially significant dispute to the PTAB docket and is one that patent litigators, prosecution counsel, and in-house IP teams may want to track closely.

At this stage, the publicly available docket information identifies Zoom Communications, Inc. as the petitioner, but the initial case caption does not, by itself, reveal the patent owner or the patent number being challenged.

A new inter partes review, IPR2026-00469, was filed at the Patent Trial and Appeal Board on September 3, 2026, opening what could become an important dispute for patent owners, petitioners, and portfolio managers watching PTAB filing trends. The proceeding is captioned EverWave Inc., indicating that EverWave is central to the challenged patent dispute.

At this early stage, the docket entry signals the start of a PTAB challenge but does not, from the case caption alone, reveal the full set of party details, the specific patent number at issue, or the precise statutory grounds asserted in the petition.

Apple has launched a new inter partes review at the Patent Trial and Appeal Board, filing IPR2026-00445 on August 25, 2026. At this stage, the public docket identifies the petitioner as Apple Inc., but practitioners will want to watch closely for the petition and accompanying exhibits to clarify the specific patent being challenged, the real party-in-interest disclosures, and the precise prior-art combinations Apple is advancing.

Even from the opening docket information, this proceeding is worth tracking.

A new post-grant review at the Patent Trial and Appeal Board could be one to watch for companies operating in the dental implant and broader medical-device space. On August 11, 2026, Straumann USA, LLC filed PGR2026-00070, asking the PTAB to review a recently issued patent.

A new post-grant review petition has been filed at the Patent Trial and Appeal Board against Straumann USA, LLC, opening what could become a closely watched dispute for practitioners in the dental and medical-device patent space. The proceeding, PGR2026-00070, was filed on August 11, 2026. View full case on Docket Alarm

At this early stage, the PTAB docket identifies Straumann USA, LLC in the case caption, but practitioners will want to watch the filing record closely to confirm the specific patent number at issue, the named petitioner, and the precise claims challenged once the petition and related papers are available through the docket.

A new post-grant review at the Patent Trial and Appeal Board could be worth close attention for companies operating in the dental implant and medical device space. In PGR2026-00070, filed on August 11, 2026, the proceeding is captioned Straumann USA, LLC, signaling a challenge to a recently issued patent associated with one of the best-known names in dental technology.

At this stage, the docket entry identifies the matter by party name and PTAB number, but practitioners will want to watch for the petition and related filings to clarify the specific patent claims at issue, the identity of the petitioner, and the precise invalidity theories being advanced.

Meta Platforms, Inc. has launched a new inter partes review at the Patent Trial and Appeal Board, filing IPR2026-00420 on August 7, 2026. The petition opens another closely watched PTAB contest involving a major technology company and underscores how frequently the Board remains central to high-stakes patent strategy.

At this early stage, the docket identifies the proceeding by petitioner name—Meta Platforms, Inc.—but the publicly available case caption information does not yet disclose the full patent details or the patent owner in the materials summarized here.

Zoom Communications, Inc. has launched a new challenge at the Patent Trial and Appeal Board, filing inter partes review petition IPR2026-00424 on July 24, 2026. For patent litigators and in-house IP teams, the case is worth watching both for what it may reveal about Zoom’s defensive patent strategy and for how the Board addresses the prior-art arguments once the petition and supporting papers are fully joined on the docket.

At this stage, the publicly available case caption identifies Zoom Communications, Inc. as the petitioner, but practitioners should review the underlying filings to confirm the patent owner, the specific U.S. patent number being challenged, and the claims at issue. Those details typically frame the entire dispute: whether the challenged patent covers core communications, conferencing, networking, or collaboration functionality, and whether the petition is aimed at neutralizing litigation exposure, licensing pressure, or competitive risk.

As with any IPR, the key battleground will be the grounds for review. PTAB petitions commonly rely on anticipation or obviousness theories under 35 U.S.C. §§ 102 and 103, built from combinations of patents, printed publications, and expert declarations.